Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rees

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1987
Acute myeloid leukaemia (AML)J K Rees
The New England Journal of Medicine|March 25, 1993
Managed care or mangled care?M K Rees
Current Opinion in Oncology|January 1, 1993
Aspects of treatment of acute myeloid leukemia in adultsJ K Rees
The New England Journal of Medicine|November 12, 1981
Acute myelogenous leukemia in remissionJ K Rees
EDTNA/ERCA Journal (English Ed.)|August 11, 2006
Caring for people who are dying on renal wards: a retrospective studyH Noble, K Rees
Nursing Times|February 17, 1993
Wound care. Prescribing potentialA While, K Rees
Seminars in Oncology|June 1, 1987
Comparison of 1 + 5 DAT and 3 + 10 DAT followed by COAP or MAZE consolidation therapy in the treatment of acute myeloid leukemia: MRC ninth AML trialJ K Rees, R Gray
Dermatology Online Journal|June 24, 2011
Feline-transmitted sporotrichosis: A case study from CaliforniaRachel K Rees, John E Swartzberg
Pathology, Research and Practice|April 1, 1990
Auer bodies in acute myeloid leukaemia patientsH T Hassan, J K Rees
Lancet (London, England)|June 24, 1978
D.A.T. (daunorubicin, cytarabine, 6-thioguanine) in acute myeloid leukaemiaJ K Rees, F G Hayhoe
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1987
Acute myeloid leukaemia (AML)J K Rees
The New England Journal of Medicine|March 25, 1993
Managed care or mangled care?M K Rees
Current Opinion in Oncology|January 1, 1993
Aspects of treatment of acute myeloid leukemia in adultsJ K Rees
The New England Journal of Medicine|November 12, 1981
Acute myelogenous leukemia in remissionJ K Rees
EDTNA/ERCA Journal (English Ed.)|August 11, 2006
Caring for people who are dying on renal wards: a retrospective studyH Noble, K Rees
Nursing Times|February 17, 1993
Wound care. Prescribing potentialA While, K Rees
Seminars in Oncology|June 1, 1987
Comparison of 1 + 5 DAT and 3 + 10 DAT followed by COAP or MAZE consolidation therapy in the treatment of acute myeloid leukemia: MRC ninth AML trialJ K Rees, R Gray
Dermatology Online Journal|June 24, 2011
Feline-transmitted sporotrichosis: A case study from CaliforniaRachel K Rees, John E Swartzberg
Pathology, Research and Practice|April 1, 1990
Auer bodies in acute myeloid leukaemia patientsH T Hassan, J K Rees
Lancet (London, England)|June 24, 1978
D.A.T. (daunorubicin, cytarabine, 6-thioguanine) in acute myeloid leukaemiaJ K Rees, F G Hayhoe
Pageof 12